Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort.
Greenawalt DM, Dobrin R, Chudin E, Hatoum IJ, Suver C, Beaulaurier J, Zhang B, Castro V, Zhu J, Sieberts SK, Wang S, Molony C, Heymsfield SB, Kemp DM, Reitman ML, Lum PY, Schadt EE, Kaplan LM. Greenawalt DM, et al. Among authors: heymsfield sb. Genome Res. 2011 Jul;21(7):1008-16. doi: 10.1101/gr.112821.110. Epub 2011 May 20. Genome Res. 2011. PMID: 21602305 Free PMC article.
A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.
Aronne LJ, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan AG, Shapiro D, Heymsfield SB, Kaufman KD, Amatruda JM. Aronne LJ, et al. Among authors: heymsfield sb. Int J Obes (Lond). 2010 May;34(5):919-35. doi: 10.1038/ijo.2010.21. Epub 2010 Feb 16. Int J Obes (Lond). 2010. PMID: 20157323 Clinical Trial.
Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission.
Sala P, Torrinhas RSMM, Fonseca DC, Machado NM, Singer J, Singer P, Ravacci GR, Belarmino G, Ferreira BAM, Marques M, Ishida RK, Guarda IFMS, de Moura EGH, Sakai P, Santo MA, Sunaga DY, Heymsfield SB, Bezerra DPDS, Corrêa-Giannella ML, Waitzberg DL. Sala P, et al. Among authors: heymsfield sb. Nutrition. 2020 Nov-Dec;79-80:110885. doi: 10.1016/j.nut.2020.110885. Epub 2020 Jun 4. Nutrition. 2020. PMID: 32707229
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake.
Addy C, Wright H, Van Laere K, Gantz I, Erondu N, Musser BJ, Lu K, Yuan J, Sanabria-Bohórquez SM, Stoch A, Stevens C, Fong TM, De Lepeleire I, Cilissen C, Cote J, Rosko K, Gendrano IN 3rd, Nguyen AM, Gumbiner B, Rothenberg P, de Hoon J, Bormans G, Depré M, Eng WS, Ravussin E, Klein S, Blundell J, Herman GA, Burns HD, Hargreaves RJ, Wagner J, Gottesdiener K, Amatruda JM, Heymsfield SB. Addy C, et al. Among authors: heymsfield sb. Cell Metab. 2008 Jan;7(1):68-78. doi: 10.1016/j.cmet.2007.11.012. Cell Metab. 2008. PMID: 18177726 Free article. Clinical Trial.
A computational model to determine energy intake during weight loss.
Thomas DM, Schoeller DA, Redman LA, Martin CK, Levine JA, Heymsfield SB. Thomas DM, et al. Among authors: heymsfield sb. Am J Clin Nutr. 2010 Dec;92(6):1326-31. doi: 10.3945/ajcn.2010.29687. Epub 2010 Oct 20. Am J Clin Nutr. 2010. PMID: 20962159 Free PMC article.
806 results